Skip to main content

Sjogrens

Answering questions on how COVID-19 affects rheumatic patients

Nov 10, 2020

As we inch closer to a possible vaccine for COVID-19, we are finally filling in the details on how the pandemic is affecting every aspect of our patient’s lives.

Read Article
Don’t forget to check the eyes. Dr Kolfenbach. Top secret and Pearls #ACR20 @RheumNow It’s also useful for dx #sjogren #sarcoidodis #Ig G4 https://t.co/dxmwuwrPqz
Nov 08, 2020
Myths surrounding #sjogren. Complications of severe dry eye. Dr Akpek #ACR20 @RheumNow https://t.co/gnZJfcpsGn
Nov 08, 2020
Living with #Sjogren #syndrome. Tips for dry mouth management. Dr Papas #ACR20 @RheumNow @ramos_casals https://t.co/uw4NH3yhpn
Nov 08, 2020
#sjogren #syndrome poster session #ACR20 @RheumNow Clinical characteristics: lung, pregnancy,smoking, cervical lesions, anti La, childhood. https://t.co/QN4FVvQrYN
Nov 08, 2020
Management of elderly patients with rheumatic diseases. Dr Rajasimhan. #ACR20 @RheumNow. Also we are near of first therapeutic recommendations of elderly #sjogren syndrome @ramos_casals @p_brito_zeron https://t.co/yjGrSTWV1K
Nov 07, 2020
Editors Pick for #ACR20—Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial https://t.co/cunDxVl5XG https://t.co/OGItXCuWDI
The Lancet Rheumatology @TheLancetRheum( View Tweet )
Nov 07, 2020
Lung disease in primary #SjogrensSyndrome is common; both conditions were diagnosed at the same time in 43% of patients, found an #ACR20 study from @joannamarco @GGRheumdoc + @UW @uofcincy colleagues. “Close monitoring is warranted” to make sure lung function is not declining. https://t.co/MpA0Rq2uVR
CreakyJoints.org @CreakyJoints( View Tweet )
Nov 06, 2020
Hand OA Rx strikes out. HCQ Rx neg and colchicine Trial negative. I wouldn’t put hand OA as same category of no Rx as for SSc and Sjogrens but agree though nuts to crack @eular_org @CRASCRRheum @earlyarthritis #EULAR2020 https://t.co/QRe3UpKpbz

Janet Pope @Janetbirdope( View Tweet )

Jun 07, 2020
#EULAR2020 OP0096 Dr. L Chatzis study on Sjogren: 1. 2nd most common autoimm dz in women 2. women:men ratio 20:1 (not 9:1) 3. 2 types Ro-Ab: nuc. Ro60 (assc w/La)and cytopls. Ro52 (assc w/ILD/myositis) 4. Seroneg. Sjogren's (neg Ro/La/RF) good prognosis:⬇️lymphoma @RheumNow https://t.co/fV3ltQqnkf
Jun 06, 2020
Primary Sjogren’s syndrome showed benefit of leflunomide + #Hydroxychloroquine vs placebo - past neg RCT of HCQ for PSS Sicca (dry eyes/mouth) so is it just leflunomide that works or combo? Likely pt selection - arthritis and rash likely respond to either @RheumNow @CRASCRRheum https://t.co/lsIeG2uv2H

Janet Pope @Janetbirdope( View Tweet )

Jun 06, 2020
Yet another NEGATIVE Trial in Hand OA. Add Hand OA to the list that Includes Scleroderma, Sjogrens and CRPS as untreatable diseases with large unmet needs! https://t.co/cMMqmeo19N

Dr. John Cush @RheumNow( View Tweet )

Jun 05, 2020

RheumNow Podcast- Corona Increases RA Risk (3.13.20)

Mar 13, 2020

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Read Article

Don't Blame the Weather in Sjogren's

Mar 03, 2020

Seasonal variations in symptoms -- commonly reported by patients with rheumatic diseases -- were not observed in a large cohort of patients with primary Sjogren's syndrome, French investigators found.

On a combined endpoint that reflected the three main symptoms of pain, fatigue, and

Read Article

RheumNow Podcast - RWCS Quick Hits (2.14.20)

Feb 14, 2020

Dr. Jack Cush reviews the highlights from the 2020 RWCS meeting in Maui, Hawaii.

Read Article

EULAR Recommendations on Sjögren’s Syndrome

Feb 03, 2020

The European League Against Rheumatism (EULAR) has established an international collaborative group (EULAR SS Task Force) to develop the first EULAR evidence and consensus-based recommendations for the management of patients with Sjogens syndrome (SjS).

The Task Force included

Read Article

RheumNow Podcast- The Down Side of Steroids (1.17.20)

Jan 17, 2020

Dr. Jack Cush reviews the journal reports and news from RheumNow.com.
Be sure to register for RheumNow Live 3/13/2020 in Fort Worth
Rheumnow.live.

Read Article

ACR/EULAR Classification Criteria for IgG4 Related Disease

Dec 11, 2019

IgG4-related disease (IgG4-RD) is a relatively new disorder since 2003, and may present as a diagnostic challenge as it can cause fibroinflammatory pathology in nearly any organ. 

A EULAR workgroup set out to develop and validate an international set of classification criteria for IgG4-

Read Article

RheumNow Podcast –Favorites of ACR 2019 (11.22.19)

Nov 22, 2019

Dr. Jack Cush recaps standout presentations and information from ACR 2019 held in Atlanta November 9-12, 2019.

Read Article

Sjogren's Syndrome at Risk for Psychiatric Disorders

Aug 02, 2019

A population-based claims study from Taiwan shows significantly increased incidences of depressive disorder, anxiety disorder, and sleep disorder in patients with primary Sjögren’s syndrome (pSS). 

Taiwan’s National Health Insurance Research Database was the source of this retrospective

Read Article

RheumNow Podcast – EULAR 2019 Streamin' - (6.14.19)

Jul 05, 2019

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. Dr. Jack Cush reports from Madrid on several novel presentations from EULAR 2019, including low-dose steroids in hand OA, ABA vs. ADA in double positive RA patients, psoriasis predictors of PsA, tildrakizumab and

Read Article

EULAR 2019 - Day 1 Report

Jul 01, 2019

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. Here are a few of the highlights from day 1 EULAR in Madrid, including another IL-23 inhibitor, BTK inhibition, abatacept in Sjogren's syndrome, don't repeat the ANA, and drug free remission in systemic JIA.

Read Article

Sjögren's Syndrome Differs in Minorities

Jun 25, 2019

Minority groups in the U.S. have differing rates of Sjögren's syndrome and exhibit distinct clinical patterns of the disease, a large cross-sectional study revealed.

The percentage of American Indians in a SS cohort of 610 patients was much higher than expected, at 25.3%, whereas the percentage

Read Article

RheumNow Podcast – EULAR 2019 Streamin' - (6.14.19)

Jun 14, 2019

Dr. Jack Cush reports from Madrid on several novel presentations from EULAR 2019.

1. Genovese Vagal nerve stimulator in RA

2.

Read Article

EULAR 2019 - Day 1 Report

Jun 12, 2019

Here are a few of the highlights from day 1 EULAR in Madrid. 

Read Article
×